Research

What Is Epitalon? The Telomerase Peptide Explained

Epitalon, also spelled Epithalon, is a tiny four-amino-acid peptide at the center of a lot of longevity talk. Its reputation comes from studies suggesting it can switch on telomerase, the enzyme that protects chromosome ends. In July 2026, an FDA advisory committee recommended it for the compounding list for insomnia. This guide explains what Epitalon is, what the evidence shows, and where the claims outrun the data.

Reviewed for accuracy · Last reviewed October 19, 2026

What Is Epitalon?

Epitalon is a synthetic tetrapeptide: Ala-Glu-Asp-Gly. It was developed by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology as a synthetic version of epithalamin, an extract from the pineal gland.

It is part of a group Khavinson called peptide bioregulators, short peptides proposed to influence gene activity in specific tissues. Pinealon, Vilon and Thymalin come from the same research program.

How Does Epitalon Work?

Research has focused on three proposed mechanisms:

  • Telomerase activation: telomeres are protective caps on chromosomes that shorten as cells divide. Telomerase rebuilds them. A 2003 study reported that Epitalon switched on telomerase and lengthened telomeres in human fibroblast cells in a dish.
  • Melatonin and circadian rhythm: in aged monkeys and rats, Epitalon was reported to restore the nightly rise in melatonin, a hormone that declines with age.
  • Antioxidant effects: animal studies report increased activity of antioxidant enzymes.

What Does the Research Show?

Cells. The telomerase findings come from cultured cells. Cell studies are an early step and often do not translate into effects in the whole body.

Animals. Studies from the Khavinson group reported longer average lifespan and fewer tumors in some mouse and rat strains. Independent replication by other labs is limited.

Humans. Russian studies of epithalamin and Epitalon in older adults reported better sleep, hormone profiles and survival over long follow-up periods. These studies were small and mostly from one research group, and they are not considered strong evidence by Western regulators.

AreaWhat studies showEvidence type
Telomerase / telomeresActivation and lengthening in human cellsCell studies
MelatoninRestored nightly melatonin in aged animalsAnimal
LifespanLonger average lifespan in some rodentsAnimal, limited replication
Human aging outcomesPositive reports, small studiesLow-quality human data

A Note on Telomerase and Safety

Telomerase is a double-edged sword. It protects healthy cells from aging, but most cancer cells also rely on telomerase to keep dividing. Researchers have raised the theoretical concern that switching it on could help existing cancer cells. Khavinson’s animal studies reported fewer tumors rather than more, but this question has not been settled in people. Reported side effects in available studies were minimal, but formal safety trials have not been done.

Epitalon and the 2026 FDA Panel Vote

On July 24, 2026, the FDA’s Pharmacy Compounding Advisory Committee narrowly voted to recommend adding Epitalon (free base and acetate forms) to the 503A Bulks List for insomnia. FDA staff had recommended against it.

  • The vote is advisory only.
  • Epitalon is not FDA-approved.
  • Compounding remains off-limits until the FDA completes rulemaking.

Epitalon and the Khavinson Bioregulators

Epitalon is the best-known of a family of short peptides developed by Vladimir Khavinson. Each is claimed to target a specific tissue:

PeptideSequenceTissue target (claimed)
EpitalonAla-Glu-Asp-GlyPineal gland
PinealonGlu-Asp-ArgBrain
VilonLys-GluImmune system
CartalaxAla-Glu-AspCartilage
ThymalinThymic peptide complexThymus / immune
CortagenAla-Glu-Asp-ProBrain cortex

The bioregulator theory. Khavinson proposed that very short peptides can enter cells and bind to DNA to switch specific genes on or off, restoring tissue function lost with age. This idea is not widely accepted outside Russia and most supporting research comes from the same institute.

Epitalon vs NAD+ and other longevity compounds. Epitalon is often stacked with NAD+, MOTS-c or senolytics like FOXO4-DRI. These target different aging pathways (telomeres, cellular energy and senescent cells), and none of the combinations has been studied together.

Buying Research-Grade Epitalon: What to Check

Products sold as Epitalon by research suppliers are laboratory chemicals, not medicines. They are not made under drug manufacturing rules, so quality varies a lot between vendors. If you are evaluating an Epitalon supplier for lab research, these are the checks that matter:

  • Batch-specific COA: the certificate should match the lot number on your vial, not a generic sample.
  • Independent lab: testing should come from a named third-party lab, ideally with a way to verify the report online.
  • Identity, not just purity: HPLC purity alone does not confirm the right molecule; look for mass spectrometry (MS) identity confirmation.
  • Endotoxin and sterility results: these matter for any injectable research material.
  • Correct fill amount: the measured content should be close to the labeled milligrams.

Our Trusted Sources page lists vendors we track, with current community codes. Our guide to reading a certificate of analysis explains each line of a COA.

Key Takeaways

  • Epitalon is a four-amino-acid synthetic version of a pineal gland extract.
  • It activated telomerase in human cells in a 2003 study.
  • Animal studies report restored melatonin and longer lifespan, mostly from one lab.
  • Human evidence is limited and low quality.
  • An FDA panel recommended it for compounding in 2026; it is not FDA-approved.

Frequently Asked Questions

What is Epitalon?

Epitalon (Epithalon) is a synthetic four-amino-acid peptide, Ala-Glu-Asp-Gly, developed in Russia as a version of the pineal extract epithalamin.

Does Epitalon lengthen telomeres?

A 2003 study found it activated telomerase and lengthened telomeres in human cells grown in a lab. This has not been shown in controlled human trials.

Is Epitalon the same as Epithalon?

Yes. They are two spellings of the same peptide.

Is Epitalon FDA-approved?

No. An FDA advisory committee recommended it for the compounding list in July 2026 for insomnia, but the FDA has not finalized that and it is not an approved drug.

Is Epitalon safe?

Formal safety trials have not been done. Researchers have raised theoretical concerns because telomerase is also used by cancer cells.

Sources

  • Khavinson et al. (2003) – Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells
  • Khavinson et al. – Peptide bioregulators and aging, St. Petersburg Institute of Bioregulation and Gerontology
  • NCPA – FDA advisory committee nominates six peptides for pharmacies to compound (July 31, 2026)
  • Frier Levitt – FDA PCAC peptide vote: what the 503A recommendations mean (2026)

MLCR SCTY provides educational information, not medical or legal advice. Research-use-only products are not intended for human consumption.